Osteoarthritis has long been seen as simple wear and tear. But a new review of the science tells a more complex story. It shows that joint damage is driven by a chain reaction involving mechanical stress, the immune system, and metabolic signals all converging on a key inflammatory pathway called NF-κB.
This isn't a single study with new data. It's a big-picture look at existing research. The authors argue that to truly help people with osteoarthritis, treatments need to target this integrated system rather than just one piece. They suggest that future therapies might need to be tailored to each person's specific pattern of inflammation.
The review does not offer a new drug or treatment. It's a roadmap for researchers. The hope is that by understanding how these different factors work together, scientists can design smarter, more personalized treatments that restore balance in the joint.
For now, this is an early step. The ideas need to be tested in real patients. But for the millions living with osteoarthritis pain, this framework could eventually lead to more effective options.